🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
NCT06534658Alzheimer Disease, Image
Ruijin Hospital
Observational
1,000
Beijing, Hanzhong, Cangzhou, Shijiazhuang, Qingdao, Shanghai, Shenyang
2020-07-30
Active, closed
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
NCT04191304Hypereosinophilic Syndrome
DrugBenralizumab
AstraZeneca
Phase 3
134
Chengdu, Shanghai, Tianjin, Xiamen, Zhengzhou
2020-07-20
Active, closed
Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
NCT04208178Advanced HER2+Breast Cancer
DrugsAlpelisib·Pertuzumab·Trastuzumab
Novartis Pharmaceuticals
Phase 3
19
Changchun, Shanghai
2020-07-16
Active, closed
Linerixibat Long-term Safety, and Tolerability Study
NCT04167358Cholestasis
GlaxoSmithKline
Phase 3
242
Beijing, Changchun, Chongqing, Guangzhou, Nanchang, Nanjing, Shanghai, Tianjin
2020-07-14
Recruiting
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
NCT04316364Non-Small-Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
537
Beijing, Guangzhou, Zhengzhou, Nanjing, Shanghai, Chengdu, Hangzhou
2020-07-14
Active, closed
A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors
NCT04511871Solid Tumor, Gastric Cancer, Breast Cancer, Ovarian Cancer
Shanghai PerHum Therapeutics Co., Ltd.
Phase 1
12
Shanghai
2020-07-09
Active, closed
A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene
NCT04395677Non Small Cell Lung Cancer
DrugTaletrectinib
Nuvation Bio Inc.
Phase 2
173
Shanghai
2020-07-07
Recruiting
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
NCT04299581Intrahepatic Cholangiocarcinoma
DrugCamrelizumab
Fudan University
Phase 2
25
Shanghai
2020-07-07
Active, closed
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
NCT04111419Atrial Fibrillation, Hypertension
DrugAllisartan Isoproxil
Shanghai Jiao Tong University School of Medicine
Phase 4
1,200
Shanghai
2020-07-01
Active, closed
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
NCT04273945Pulmonary Arterial Hypertension
DrugMacitentan
Actelion
Phase 3
935
Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Shanghai, Shenyang, Tianjin
2020-06-30
Active, closed
Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL
NCT06728631Oral Cavity Cancer, Premalignant Lesion
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
22
Shanghai
2020-06-30
Not yet open
An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
NCT04443543Rectal Cancer
Drugs5Fluorouracil·Irinotecan·Tislelizumab·Oxaliplatin
Fudan University
Phase 2
222
Shanghai
2020-06-22
Active, closed
Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
NCT04270409Plasma Cell Myeloma
DrugsIsatuximab SAR650984·Montelukast·Diphenhydramine·Acetaminophen
Sanofi
Phase 3
337
Hangzhou, Nanchang, Shanghai, Shenyang, Tianjin
2020-06-16
Active, closed
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
NCT04379596Gastric Cancer
DrugsVolrustomig·Rilvegostomig·Fluorouracil·Trastuzumab deruxtecan
AstraZeneca
Phase 2
452
Chengdu, Guangzhou, Hefei, Shanghai, Shenyang, Wuhan, Zhengzhou
2020-06-03
Recruiting
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
NCT04187443Diabetic Macular Edema, Macular Edema, Type 2 Diabetes With Diabetic Macular Edema, Type 1 Diabetes With Diabetic Macular Edema
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Phase 1
45
Changsha, Chengdu, Shanghai
2020-06-02
Recruiting
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
NCT04183712Gallbladder Carcinoma
DrugsGemcitabine and oxaliplatin·Afatinib
Shanghai Jiao Tong University School of Medicine
Phase 2
102
Shanghai
2020-06-01
Active, closed
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227Esophagus Cancer, Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Radiation Therapy
DrugsPaclitaxel·Carboplatin
Fudan University
Phase 2
70
Shanghai
2020-05-30
Active, closed
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
NCT04398914Breast Cancer Invasive
DrugsTrastuzumab emtansine·Pyrotinib·Pertuzumab·Trastuzumab
Shanghai Jiao Tong University School of Medicine
Phase 2
216
Shanghai
2020-05-30
Active, closed
Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma
NCT04261673Epidural Hematoma, Brain Herniation, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Not applicable
120
Shanghai
2020-05-23
Active, closed
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
NCT04383275Breast Cancer
Fudan University
Phase 2
367
Shanghai
2020-05-20
Recruiting
Real World Study of Classic Infectious Disease
NCT04020536Brucelloses, Epidemic Hemorrhagic Fever, Kala-Azar
Huashan Hospital
Observational
10,000
Shanghai
2020-05-13
Active, closed
A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy
NCT04371783IVF, Frozen Embryo Transfer
ShangHai Ji Ai Genetics & IVF Institute
Not applicable
828
Shanghai
2020-05-04
Recruiting
VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study
NCT04414865Aortic Valve Stenosis
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Observational
100
Shanghai
2020-04-26
Recruiting
Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
NCT04281641HER2-positive Breast Cancer
Fudan University
Not applicable
94
Shanghai
2020-04-21
Active, closed
A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
NCT04280081Solid Tumor, Medullary Thyroid Cancer
DrugSelpercatinib
Eli Lilly and Company
Phase 2
77
Beijing, Guangzhou, Changsha, Changchun, Jinan, Shanghai, Tianjin, Hangzhou
2020-03-16
Active, closed
Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)
NCT04296175Triple-negative Breast Cancer
DrugsCarbo·Epirubicin·Paclitaxel·Carboplatin
Fudan University
Phase 3
808
Shanghai
2020-03-05
Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT04221542Prostate Cancer
DrugsXaluritamig·Abiraterone·Enzalutamide
Amgen
Phase 1
479
Beijing, Guangzhou, Nanchang, Shanghai, Hangzhou, Nanjing, Wenzhou
2020-03-04
Recruiting
A Pilot Study in Severe Patients With Takayasu Arteritis.
NCT04300686Takayasu Arteritis, Tocilizumab, Adalimumab, Treatment
DrugsAdalimumab·Tocilizumab
Shanghai Zhongshan Hospital
Phase 4
40
Shanghai
2020-03-01
Active, closed
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
NCT04194944Non-Small Cell Lung Cancer
DrugsSelpercatinib·Pemetrexed·Cisplatin·Carboplatin
Eli Lilly and Company
Phase 3
261
Beijing, Guangzhou, Harbin, Wuhan, Changsha, Changzhou, Changchun, Shanghai
2020-02-17
Not yet open
RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma
NCT04253847Radical Antegrade Modular Pancreatosplenectomy
Ruijin Hospital
Not applicable
224
Shanghai
2020-02-15
Active, closed
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus
NCT04276532Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis
Xiaojun Chen
Not applicable
780
Shanghai
2020-02-13
Active, closed
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
NCT04161898Takayasu Arteritis (TAK)
DrugsPrednisolone·Upadacitinib
AbbVie
Phase 3
56
Beijing, Guangzhou, Shenzhen, Shenyang, Shanghai
2020-02-04
Active, closed
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
NCT04191499Breast Cancer
DrugsInavolisib·Palbociclib·Fulvestrant
Hoffmann-La Roche
Phase 2/3
325
Beijing, Changchun, Chongqing, Fujian, Guangzhou, Hangzhou, Harbin, Shanghai
2020-01-29
Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
NCT04192344Neoplasms, Tenosynovial Giant Cell Tumor
DrugPimicotinib
Abbisko Therapeutics Co, Ltd
Phase 1
276
Beijing, Guangdong, Shijiazhuang, Zhengzhou, Nanjing, Shenyang, Shanghai, Xian
2020-01-20
Active, closed
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
NCT04175600Hypertension, Pulmonary
DrugSelexipag
Actelion
Phase 3
138
Beijing, Guangzhou, Qingdao, Shanghai, Shenyang
2020-01-16
Active, closed
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
NCT04129502Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
DrugsTAK-788·Pemetrexed·Cisplatin·Carboplatin
Takeda
Phase 3
354
Beijing, Zhengzhou, Changchun, Chengdu, Guangzhou, Hangzhou, Harbin, Shanghai
2020-01-10
Recruiting
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
NCT04519905Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Survival
DrugsPaclitaxel·Carboplatin
Fudan University
Not applicable
320
Nanjing, Shanghai
2020-01-06
Active, closed
an AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer
NCT07605663Esophageal Squamous Cell Carcinoma
Fudan University
Observational
890
Shanghai
2020-01-01
Recruiting
AAA-CTA Cohort Registry
NCT07039825Abdominal Aortic Aneurysm, Image
RenJi Hospital
Observational
1,000
Shanghai
2020-01-01
Recruiting
Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever
NCT04270786Safety Issues
Shanghai Jiao Tong University School of Medicine
Not applicable
200
Shanghai
2020-01-01
By invitation
The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)
NCT06685939Pancreatic Neoplasms
Zhijun Bao
Observational
220
Shanghai
2020-01-01
Recruiting
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NCT04078230Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
168
Beijing, Guangzhou, Changsha, Hohhot, Shanghai, Xi’an, Chengdu, Hanzhou
2020-01-01
Recruiting
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
NCT06195228Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University
Phase 4
800
Fuzhou, Zhengzhou, Wuhan, Hohhot, Shanghai, Shanxi, Hangzhou, Beijing
2020-01-01
Recruiting
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT07176962Gall Bladder Cancer, Intrahepatic Cholangiocarcinoma (Icc), Extrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma
Yingbin Liu, MD, PhD, FACS
Observational
1,800
Shanghai
2020-01-01
Active, closed
A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
NCT04169997Ovarian Cancer
Impact Therapeutics, Inc.
Phase 3
404
Guanzhou, Shanghai
2019-12-24
Active, closed
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer
NCT04193059Breast Cancer
DrugsEpirubicin·Pertuzumab·Trastuzumab·Docetaxel
Fudan University
Phase 3
1,560
Shanghai
2019-12-20
Recruiting
Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
NCT04254263Locally Advanced Breast Cancer
RenJi Hospital
Phase 3
316
Shanghai
2019-12-16
Recruiting
Registry Study on "Control Nocturnal Hypertension to Reach the Target "
NCT04137549Nocturnal Hypertension
Shanghai Institute of Hypertension
Observational
4,500
Shanghai
2019-12-01
Active, closed
A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center
NCT06949241Pemphigus Disease, Rituximab (RTx), Intravenous Immunoglobulin
Ruijin Hospital
Observational
76
Shanghai
2019-12-01
Active, closed
A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
NCT04025879Carcinoma, Non-Small-Cell Lung
DrugsNivolumab·Pemetrexed·Docetaxel·Paclitaxel
Bristol-Myers Squibb
Phase 3
461
Beijing, Fuzhou, Hubei Sheng, Changsha, Shanghai, Chengdu, Hangzhou
2019-11-05
Recruiting
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
NCT04072042Sarcoma
DrugApatinib
Ruijin Hospital
Phase 2
30
Shanghai
2019-10-30
Recruiting
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
NCT06550713Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
DrugAzacitidine
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
100
Beijing, Shijiazhuang, Harbin, Shanghai, Chengdu, Tianjin
2019-10-22
Recruiting
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
NCT03983226Ovarian Cancer Recurrent, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
DrugNiraparib
Shanghai Gynecologic Oncology Group
Phase 2
167
Shanghai, Guangzhou, Hangzhou
2019-10-18
Recruiting
Overweight and Obesity and Puberty Development Cohort Study
NCT04113070Precocious Puberty, Overweight and Obesity
Shanghai Jiao Tong University School of Medicine
Observational
14,100
Shanghai
2019-10-11
Active, closed
Acute Health Effects of Traffic-Related Air Pollution Exposure
NCT04153539Cardiovascular System, Respiratory System
Fudan University
Not applicable
69
Shanghai
2019-10-09
Recruiting
Xinqiao High-risk Cohort of Diabetes(NICE)
NCT07281170Pre Diabetic
Shanghai General Hospital, China
Observational
7,000
Shanghai
2019-10-08
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
225
Beijing, Shanghai
2019-10-03
Recruiting
Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations
NCT04113486Carcinoma, Renal Cell
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
400
Shanghai
2019-10-01
Recruiting
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
NCT04937283Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
690
Hefei, Nanyang, Nantong, Xuzhou, Yancheng, Jinan, Shanghai, Hangzhou
2019-10-01
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Beijing, Guangzhou, Changsha, Shanghai
2019-09-23
Active, closed
Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System
NCT04023370Iliac Artery Stenosis
Bentley InnoMed GmbH
Not applicable
182
Beijing, Shanghai, Suzhou, Tianjin, Wuhan, Zhejiang
2019-09-19
Active, closed
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
NCT04076059Metastatic Hormone Sensitive Prostate Cancer
Astellas (Beijing) Pharmaceutical R&D Co., Ltd.
Phase 3
180
Beijing, Changchun, Changsha, Fuzhou, Guangzhou, Hangzhou, Nanchang, Shanghai
2019-09-11
Recruiting
Sentinel Node Biopsy Vs Observation After Axillary PET
NCT04072653Breast Cancer
Fudan University
Not applicable
1,528
Shanghai
2019-09-04
Active, closed
A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors
NCT06239155Advanced Solid Tumors, Hepatocellular Carcinoma
DrugAST-3424
Ascentawits Pharmaceuticals, Ltd
Phase 1/2
51
Guangzhou, Zhengzhou, Nanjing, Shenyang, Shanghai, Hangzhou
2019-09-03
Recruiting
Real World Study of End-stage Liver Disease in China
NCT04037995End Stage Liver DIsease, Complication
Huashan Hospital
Observational
10,000
Shanghai
2019-09-01
Active, closed
A Monotherapy in Subjects With Advanced Solid Tumors
NCT04221204Solid Tumor, Adult
3D Medicines (Beijing) Co., Ltd.
Phase 1
42
Shanghai
2019-09-01
Recruiting
Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura
NCT03647852Henoch-Schönlein Purpura
DrugsIVIG·Methylprednisolone
Children's Hospital of Fudan University
Not applicable
150
Shanghai
2019-09-01
Recruiting
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
NCT04135664Esophageal Cancer
Shanghai Chest Hospital
Phase 3
176
Nanchang, Shanghai, Tianjin
2019-09-01
Recruiting
Neoadjuvant Radiotherapy for Malignant Lacrimal Sac Tumors
NCT04016675Malignant Tumor of Lacrimal Drainage Structure
Eye & ENT Hospital of Fudan University
Not applicable
94
Shanghai
2019-09-01
Recruiting
Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)
NCT04187599Myopia
CooperVision International Limited (CVIL)
Not applicable
250
Shanghai, Tianjin, Wenzhou
2019-08-29
Active, closed
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359Dermatitis Atopic
Sanofi
Observational
1,860
Beijing, Changsha, Chongqing, Guangzhou, Harbin, Shanghai, Shenzhen, Suzhou
2019-08-15
Active, closed
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
NCT04077723Lymphoma, Non-Hodgkin
DrugsGlofitamab·Tocilizumab·Obinutuzumab
Hoffmann-La Roche
Phase 1/2
498
Beijing, Jinan, Shanghai, Xiamen
2019-08-13
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Beijing, Guangzhou, Shanghai, Chengdu, Tianjin, Hangzhou
2019-08-12
Active, closed
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NCT03977129Primary Valvular Heart Disease With Comorbid Coronary Artery Disease, Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart Disease
Ruijin Hospital
Not applicable
792
Hefei, Fuzhou, Zhengzhou, Changsha, Jinan, Qingdao, Shanghai, Tianjin
2019-08-04
Active, closed
A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
NCT03736226Cardiovascular Diseases
Boston Scientific Corporation
Observational
2,000
Shanghai
2019-07-30
Recruiting
Real World Study of Chronic Viral Hepatitis
NCT04025944Hepatitis, Chronic
Huashan Hospital
Observational
10,000
Shanghai
2019-07-20
Active, closed
Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
NCT07491211NSCLC (Advanced Non-small Cell Lung Cancer), Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Osimertinib, Stereotactic Radiation
DrugOsimertinib
Fudan University
Observational
300
Shanghai, Wuhan
2019-07-19
Active, closed
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
NCT03932136Clinical High Risk Syndrome of Psychosis
Shanghai Jiao Tong University School of Medicine
Phase 3
300
Guangzhou, Zhengzhou, Changsha, Suzhou, Shanghai, Shenzhen, Tianjin
2019-07-14
Active, closed
A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
NCT03980054Breast Cancer
DrugPyrotinib
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
2,135
Shanghai
2019-07-12
Active, closed
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
NCT04008797Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms
DrugsE7386·Doxorubicin·Lenvatinib·Paclitaxel
Eisai Inc.
Phase 1/2
301
Beijing, Changchun, Fuzhou, Guangzhou, Jinan, Kunming, Shanghai, Shenzhen
2019-07-11
Active, closed
THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study
NCT03963349Paroxysmal Atrial Fibrillation
Biosense Webster, Inc.
Observational
150
Shanghai
2019-06-24
Active, closed
Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
NCT04126525Breast Cancer Female
DrugPyrotinib
RenJi Hospital
Phase 2
53
Shanghai
2019-06-18
Recruiting
Toric Intraocular Lens (IOL) Implantation for Management of Cataracts
NCT05797298Toric Intraocular Lens Stability, Visual Quality
Eye & ENT Hospital of Fudan University
Observational
3,000
Shanghai
2019-06-01
Recruiting
Construction of a Multi-center Clinical Research Collaboration Network for Children with Congenital Heart Disease in China
NCT06885307Congenital Heart Disease (CHD)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
35,000
Wuhan, Xining, Shanghai, Kunming, Wenzhou, Jinan
2019-06-01
Recruiting
Effect of Acupuncture on Mild to Moderate Active Crohn's Disease
NCT04187820Intestinal Disorder, Inflammatory Bowel Diseases, Crohn Disease
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
60
Shanghai
2019-06-01
Active, closed
Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study
NCT03886246Generalized Pustular Psoriasis
DrugSpesolimab
LEO Pharma
Phase 2
131
Guangzhou, Hangzhou, Shanghai, Xi'an
2019-05-29
Active, closed
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
NCT03930953Lymphoma, Non-Hodgkin
DrugsValemetostat·Tafasitamab·Golcadomide·Obinutuzumab
Celgene
Phase 1/2
438
Beijing, Guangzhou, Zhengzhou, Wuhan, Shenyang, Shanghai, Tianjin
2019-05-20
Active, closed
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes
NCT03936829Lipodystrophy Acquired, Type1diabetes
DrugCyclophosphamide
Children's Hospital of Fudan University
Not applicable
10
Shanghai
2019-04-28
Recruiting
A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
NCT03851640MCRPC
Hinova Pharmaceuticals Inc.
Phase 3
417
Shanghai
2019-04-12
Recruiting
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
NCT03813407Hyperkalaemia
DrugPumitamig
AstraZeneca
Phase 3
140
Beijing, Changsha, Chengdu, Chongqing, Hangzhou, Hefei, Shanghai
2019-04-02
Recruiting
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
NCT03713879Post ERCP Pancreatitis
Chinese University of Hong Kong
Phase 3
1,734
Xi'an, Shanghai, Tianjin, Hangzhou
2019-03-21
Active, closed
Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas
NCT05969691Glioma, Malignant, Computer-Assisted
Mingge LLC
Not applicable
18
Shanghai
2019-03-15
Active, closed
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection
NCT03859128Hepatocellular Carcinoma
DrugToripalimab
Shanghai Junshi Bioscience Co., Ltd.
Phase 2/3
427
Shanghai
2019-03-05
Recruiting
Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease
NCT03810794Alzheimer Disease, Cognitive Impairment
DrugDonepezil
Jian Pei,MD
Not applicable
180
Shanghai
2019-03-01
Recruiting
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895Esophageal Neoplasms, Lymph Node Metastases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
5,000
Shanghai
2019-03-01
Recruiting
A Real World Study of Respiratory Critical Disease.
NCT07165717ARDS (Acute Respiratory Distress Syndrome), Real World Study
Ming Zhong
Observational
500
Shanghai
2019-03-01
Recruiting
Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment
NCT03829553Breast Cancer
Ruijin Hospital
Phase 3
801
Shanghai
2019-02-21
Active, closed
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)
NCT03847857Esophageal Anastomotic Leak
Sun Yat-sen University
Phase 3
360
Guangzhou, Jieyang, Shantou, Zhongshan, Chengdu, Shanghai
2019-02-21
Recruiting
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
NCT03835312Diabetes Mellitus, Type 1, Immunologic Deficiency Syndromes
Children's Hospital of Fudan University
Not applicable
50
Shanghai
2019-02-20
Active, closed
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641Castration-Resistant Prostatic Cancer
DrugsNiraparib·Abiraterone acetate·Prednisone
Janssen Research & Development, LLC
Phase 3
765
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanjing, Ningbo, Shanghai
2019-01-25
Rows per page Showing 3601–3700 of 3827
Previous 35 36 37 38 39 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=37

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.